IXICO PLC (LSE:IXI) - Share price - Overview

Stock Report

IXICO PLC IXI

Last Price
GBX36.50

Day Change
2.00|5.80%

As of 16/01/2017
15:47:13 GMT | GBX
Minimum 15 Minutes Delay.

Last Close34.50p
Day Range33.90 - 38.00
Mkt Cap9.88Mil
52-Wk Range22.00 - 44.00
Yield %0.00
ISINGB00BCLY7L40
Volume14,150
P/E-6.02
P/S2.86
P/CF-5.79

Share Price

Total Returns 16/01/2017

 Chg (%)  
More ...
IXICO PLC-2.67 
FTSE 100 TR GBP4.54
 
Financials
201420152016
More ...
Income Statement
Turnover2.563.123.11
Operating Profit-1.89-1.39-2.87
Net Profit-1.72-1.19-2.12
Reported EPS-11.39-7.90-8.70
Balance Sheet
Current Assets4.773.825.04
Non Current Assets0.640.420.65
Total Assets5.414.245.68
Current Liabilities1.501.471.49
Total Liabilities1.601.531.60
Total Equity3.812.714.09
Cash Flow
Operating Cash Flow-2.15-1.63-1.97
Net Change in Cash1.83-1.361.25
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
26/09/2016Exercise of OptionProf Derek Hill1.0029,773298.00
01/03/2016PurchaseMs. Susan Lowther35.2528,3669,999.00
04/02/2016PurchaseProf Derek Hill33.6810,0003,368.00
03/02/2016PurchaseDr. Andy Richards32.6845,89915,000.00

Company Profile

IXICO PLC is a medical technology and diagnostics company. It provides clinical trials services to the pharmaceutical industry.The Company is engaged in developing technologies in researching and treating serious diseases.
 

Sector

Biotechnology

Market Position

1520 of 1849 Companies

Index

FTSE AIM All Share

Outlook

(06/01/2017) no outlook statement

Next Event 30/01/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)0.0014.0116.45
Div Yld (E)0.003.984.01
PEG (E)0.00-1.710.70
ROCE-61.22200.4798.67
Op Mrgn-71.62-13.17-16.27
EPS Grwth0.0012.2824.12
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Charles Spicer
Chief Executive OfficerProf Derek Hill
Chief Financial OfficerMs. Susan Lowther
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.